Mayo, Shadieya T.

HRN: 15-82-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/24/2022
11/29/2022
ORAL
500mg
Q24
T/C CAP MR S/P NSVD
Waiting Final Action 
11/24/2022
CO-AMOXICLAV 625MG (TAB)
11/24/2022
11/30/2022
ORAL
625 Mg
TID
Community Acquired Pneumonia-Low Risk
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: